Cathal Friel

Cathal Friel

CATHAL FRIEL has been putting together a group of companies in the clinical research organisation sector. Rather than competing with the multi-billion euro Icon group (which grew out of Austin Darragh’s Institute of Clinical Pharmacology), Open Orphan is instead focused on offering a clinical services business targeting the so-called orphan drug sector. Although it is... Read more »

To access this content, you must be a Phoenix subscriber.

Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!

Subscribe Now! I'm a Subscriber

Related Articles: